Expert Panel Discussion of Aducanumab

  • 19 Aug 2021
  • 6:00 PM - 7:30 PM
  • Online


  • Active members

Expert panel discussion of aducanumab:

"Trial data, implementation, and how to communicate with your patients"

When: Thursday, Aug 19, 2021 (6:00-7:30 PM)

Where: online via Zoom

Of note, the MNA has not received any funds nor has any commercial interest in the planning of this educational activity. The MNA has not taken a position in the use of Aducanumab.

Confirmed Speakers:

  • Catherine Freiman, PhD - Medical Director, US Medical Affairs Alzheimer’s Disease, Biogen.
  • Scott McGinnis, MD - Behavioral Neurologist at BWH Center for Brain Mind Medicine and investigator in the BWH Center for Alzheimer Research Treatment.
  • Kirk Daffner, MD - Chief Division of Cognitive and Behavioral Neurology, Director of Center for Brain Mind Medicine BWH.
  • Katherine Coerver, MD, PhD - Behavioral Neurologist, Rocky Mountain Neurology (Lone Tree, CO); AAN Aducanumab Workgroup  

This webinar is free of registration fees. There will be time dedicated for Q&As. You can submit your questions in advanced via email to or during the webinar through the chat. A moderator will relay all questions to the speakers.

Massachusetts Neurologic Association • 781-434-7314 •